Berenberg analyst Kerry Holford raised the firm’s price target on GSK (GSK) to 1,660 GBp from 1,600 GBp and keeps a Hold rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Novo Nordisk Stock (NVO) Jumps after Ozempic and Wegovy Prices Cut 71% under Medicare Plan
- FDA approves reformulated ranitidine tablets
- GSK upgraded to Neutral from Underperform at BofA
- GlaxoSmithKline’s Mixed Outlook: Balancing Product Launches and Patent Challenges
- RFK told CDC to change website language on autism and vaccines, NYT reports